Angitia Biopharmaceuticals is a clinical-stage biotechnology company developing novel treatments for serious musculoskeletal diseases.

Spear Bio Inc. is a biotech firm specializing in ultrasensitive immunodiagnostics and proteomics, offering advanced sensitivity in digital immunoassays and focusing on biomarker discovery and early chronic disease diagnosis.